You just read:

Aridis Pharmaceuticals Reports Positive Clinical Data from Phase 1/2a Study of Human Monoclonal Antibody AR-301 for Treating Pneumonia

News provided by

Aridis Pharmaceuticals, Inc.

05 Jan, 2017, 14:02 ET